HLA-DRB3*01:01对HPA-1a免疫女性抗体水平的剂量依赖性影响
本研究纳入130例HPA-1a免疫女性,按HLA-DRB3*01:01等位基因拷贝数分为阴性、杂合和纯合三组,比较分娩时抗HPA-1a水平及新生儿血小板计数。结果显示该等位基因对母体抗体水平呈显著剂量依赖性影响(整体P=.0032),对新生儿血小板计数呈显著反向剂量依赖性影响(整体P=.0155)。
要点
- HLA-DRB3*01:01拷贝数增加与母体抗HPA-1a水平升高相关(整体P=.0032)。
- HLA-DRB3*01:01拷贝数增加与新生儿血小板计数降低相关(整体P=.0155)。
- 该等位基因对HPA-1a免疫女性的抗体水平呈现剂量依赖性影响。
核心结论
- HLA-DRB3*01:01等位基因对HPA-1a免疫女性的母体抗HPA-1a水平呈现剂量依赖性影响。
研究设计与样本
- 研究纳入130例HPA-1a免疫女性,按HLA-DRB3*01:01等位基因拷贝数分为阴性、杂合(半合子或杂合子)和纯合三组。
- 通过测序HLA-DRB3基因第2外显子及对选定样本进行HLA-DRB3和HLA-DRB1分型确定等位基因剂量。
- 比较各组分娩时抗HPA-1a水平及新生儿血小板计数。
主要发现
- HLA-DRB3*01:01等位基因对母体抗HPA-1a水平有显著剂量依赖性效应(整体P值=.0032)。
- 0、1、2个拷贝组母体抗HPA-1a水平中位数(范围)分别为1.5 IU/mL(0.0-19.0 IU/mL)、21.1 IU/mL(0.0-1967 IU/mL)和43.7 IU/mL(1.0-980 IU/mL)。
- 母体HLA-DRB3*01:01等位基因对新生儿血小板计数有显著但方向相反的剂量依赖性效应(整体P值=.0155)。
- 0、1、2个拷贝组新生儿血小板计数中位数(范围)分别为241 × 10^9/L(59 × 10^9/L至393 × 10^9/L)、107 × 10^9/L(4 × 10^9/L至387 × 10^9/L)和32 × 10^9/L(4 × 10^9/L至352 × 10^9/L)。
关键数值与推荐
- 母体抗HPA-1a水平整体P值=.0032,组间比较显示剂量依赖性升高。
- 新生儿血小板计数整体P值=.0155,组间比较显示剂量依赖性降低。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
HLA-DRB3*01:01 is a predisposing factor for human platelet antigen 1a (HPA-1a) immunization, which is responsible for most cases of fetal and neonatal alloimmune thrombocytopenia. The aim of this study was to investigate if the HLA-DRB3*01:01 allele imposes a dose-dependent effect on anti-HPA-1a levels and neonatal platelet counts. One hundred and thirty HPA-1a-immunized women were divided into 3 groups: HLA-DRB3*01:01 negative, HLA-DRB3*01:01 hemizygous or heterozygous, and HLA-DRB3*01:01 homozygous. The dose of the HLA-DRB3*01:01 allele was determined by sequencing exon 2 of the HLA-DRB3 gene followed by HLA-DRB3 and HLA-DRB1 typing of selected samples. Anti-HPA-1a levels at time of delivery and neonatal platelet counts were compared among groups. There was a significant dose-dependent effect of the HLA-DRB3*01:01 allele on anti-HPA-1a levels (global P value [P global] = .0032). Median (range) anti-HPA-1a levels were 1.5 IU/mL (0.0-19.0 IU/mL), 21.1 IU/mL (0.0-1967 IU/mL), and 43.7 IU/mL (1.0-980 IU/mL) in women with 0, 1, and 2 copies of the HLA-DRB3*01:01 allele, respectively. There was also a significant, but opposite, dose-dependent effect of the mother's HLA-DRB3*01:01 allele on the platelet count of the newborn (P global = .0155). Median (range) neonatal platelet counts were 241 × 109/L (59 × 109/L to 393 × 109/L), 107 × 109/L (4 × 109/L to 387 × 109/L) and 32 × 109/L (4 × 109/L to 352 × 109/L) for newborns of mothers with 0, 1, and 2 copies of the HLA-DRB3*01:01 allele, respectively. Thus, the HLA-DRB3*01:01 allele exhibits a dose-dependent impact on maternal anti-HPA-1a levels in HPA-1a-immunized women.
引用
- Kjeldsen-Kragh J, Titze TL, Lie BA, et al. HLA-DRB3*01:01 exhibits a dose-dependent impact on HPA-1a antibody levels in HPA-1a-immunized women. Blood Adv. 2019. PMID: 30923048. doi:10.1182/bloodadvances.2019032227
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。